1
|
MUESTRA DE MEDICAMENTO DE USO TERAPEUTICO HARMLESS PHARMACEUTICAL RAW MATERIAL-WORKING STANDARD OF RIVAROXABAN IH PAIS DE ORIGEN INDIA
|
ALVIREY PHARMA GROUP, S.A.
|
GLIESSE PHARMACEUTICALS PRIVATE LIMITED
|
2025-07-03
|
INDIA
|
0.23 Kgs
|
2 Vial (Botellita)
|
2
|
MUESTRAS PRINCIPIO ACTIVO, PAIS DE ORIGEN INDIA HARMLESS PHARMACEUTICAL RAW MATERIAL-WORKING STANDARD OF TRIETHYL AMINE
|
ALVIREY PHARMA GROUP, S.A.
|
GLIESSE PHARMACEUTICALS PRIVATE LIMITED
|
2023-07-03
|
INDIA
|
0.05 Kgs
|
1.00 Vial (Botellita)
|
3
|
MUESTRA DE MEDICAMENTO DE USO TERAPEUTICO, PAIS DE ORIGEN INDIA HARMLESS PHARMACEUTICAL FINISHED DOSAGE FORMULATION PRODUCT LEUPROLIDE ACETATE FOR INJECTION 11.25 MG/VIAL (AS LYOPHILIZED)
|
ALVIREY PHARMA GROUP, S.A.
|
GLIESSE PHARMACEUTICALS PRIVATE LIMITED
|
2023-07-03
|
INDIA
|
8 Kgs
|
100.00 UNIT (UNIDAD)
|
4
|
MUESTRA DE MEDICAMENTO DE USO TERAPEUTICO, PAIS DE ORIGEN INDIA HARMLESS PHARMACEUTICAL FINISHED RAW MATERIAL-WORKING STANDARD OF LEUPROLIDE ACETATE USP
|
ALVIREY PHARMA GROUP, S.A.
|
GLIESSE PHARMACEUTICALS PRIVATE LIMITED
|
2023-07-03
|
INDIA
|
0.35 Kgs
|
1.00 Vial (Botellita)
|
5
|
MUESTRA INSUMO PARA REALIZAR PRUEBAS QUIMICAS PAIS DE ORIGEN ESTADOS UNIDOS CROMSIL BETA C18 HPLC COLUMN
|
ALVIREY PHARMA GROUP, S.A.
|
GLIESSE PHARMACEUTICALS PRIVATE LIMITED
|
2023-07-03
|
UNITED STATES
|
2 Kgs
|
1.00 UNIT (UNIDAD)
|